I am Consultant Ophthalmologist who is unique in being one of exceptionally few surgeons that have completed not just two years of prestigious high-volume Fellowships in Vitreoretinal Surgery, but also two years of subspecialist Fellowship training in Medical Retina, all at the internationally-renowned Moorfields Eye Hospital, London.
I specialise in state of-the-art modern micro-incision sutureless vitrectomy surgery, and premium micro-incision cataract surgery, including multifocal trifocal intraocular lenses for complete spectacle independence at all distances.
I provide completely comprehensive surgical and laser treatment of cataracts in particular premium multifocal intraocular lenses, complete assessment and surgical removal of floaters, including posterior vitreous detachment (PVD), vitreomacular traction, macular holes and epiretinal membranes.
I am also fully trained to treat most medical retina conditions including providing intravitreal injection and laser therapies for macular degeneration, retinal vein occlusions, diabetic retinopathy, diabetic maculopathy, inherited/genetic retinal disorders, uveitis
This was in addition to my general ophthalmic training, which was also predominantly based at this Centre of Excellence and one of the world’s top Eye Hospitals. I also obtained a PhD from University College London (ranked in the top five universities globally) developing state-of-the-art Gene Therapy for age-related macular degeneration as well as other retinal disorders. I have been awarded numerous prizes recognising my contribution to advancing frontiers in ophthalmology and for his teaching excellence. I am considered an expert in retinal medicine and surgery, and I'm often invited to lecture both nationally and internationally, teaching other retinal specialists.
I have an outstanding track record in research and teaching. I spent four years full-time at University College London, under the guidance of internationally-awarded Professor Robin Ali, performing cutting-edge research developing novel retinal gene-based therapies for age-related macular degeneration and inherited retinal disorders. I was awarded a PhD for this work.
I was a co-investigator in the world’s first gene therapy trial for an inherited retinopathy (New England Journal of Medicine 2008, 2015), and more recently a key investigator in the first randomised clinical evaluation of subconjunctival bevacizumab for new-onset corneal neovascularisation (British Journal of Ophthalmology, 2012). I co-designed and am the Principal Investigator in a new clinical trial based at Moorfields Eye Hospital, which will evaluate a novel radiotherapy device for the treatment of macular degeneration.
I also lead, as Principal Investigator, an NHS-funded clinical trial evaluating the role of femtosecond laser-assisted cataract surgery for NHS patients.